CD44 and head and neck squamous cell carcinoma: Likewise, Fan et al. [39] performed a meta-analysis of multiple CSC markers—including OCT4, SOX2, NANOG, ALDH1, and CD44—in HNSCC and showed that overexpression of stemness-related markers was linked to adverse survival outcomes.